Tricyclic antidepressant binding to lymphocyte membranes and changes during depression

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Imipramine and its derivatives are antidepressants that bind to specific sites.
• Lymphocyte membranes offer a peripheral model for studying neurotransmitter receptor binding.

Purpose of the Study:

• To investigate the binding characteristics of [3H]imipramine and its derivatives to lymphocyte membranes.
• To compare these binding properties with those in brain and thrombocyte membranes.
• To examine alterations in binding site density and affinity in patients with depression.

Main Methods:

• Radioligand binding assays using [3H]imipramine, [3H]desmethylimipramine, and related compounds.
• Determination of IC50 values for competing drugs and neurotransmitters.
• Analysis of binding site number (Bmax) and dissociation constant (Kd) in lymphocyte membranes from healthy individuals and depressive patients.

Main Results:

• [3H]imipramine and [3H]desmethylimipramine binding to lymphocyte membranes showed similar IC50 values to brain and thrombocyte membranes.
• The number of [3H]imipramine and [3H]desmethylimipramine binding sites was significantly increased in depressive patients.
• Dissociation constants (Kd) for these binding sites remained unchanged in depressive patients.

Conclusions:

• Lymphocyte membranes serve as a valid peripheral model for studying imipramine binding sites.
• An increased density of imipramine and desmethylimipramine binding sites in lymphocytes may be a biomarker for depression.
• These findings suggest potential alterations in serotonin transporter or related protein expression in depression.